Pearl Therapeutics Initiates PT003 Phase 3 Program for the Treatment of Individuals with Moderate-to-Severe COPD The “PINNACLE” Program will Assess Long-term Efficacy and Safety of PT003 REDWOOD CITY, CALIF., May 13, 2013 – Pearl Therapeutics Inc....
Relypsa Completes Patient Enrollment in Pivotal Phase 3 Program for the Treatment of Hyperkalemia Redwood City, CA, May 13, 2013 – Relypsa, Inc., a clinical-stage biopharmaceutical company, today announced that the company has completed enrollment of its pivotal phase...
Relypsa Announces Appointment of John Orwin as Chief Executive Officer Industry Veteran Brings Extensive Senior Biopharma Background from Firms including Genentech and Johnson & Johnson Redwood City, CA, May 15, 2013 – Relypsa, Inc., a biopharmaceutical company...
TigerText and AirWatch Partner to Offer Comprehensive Mobile Security Solution for Healthcare Device management and secure messaging solution has been selected by Community Hospice of Texas SANTA MONICA, CALIF. May 16, 2013 -TigerText, the leader in secure, real-time...
Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System SANTA ROSA, Calif., May 16, 2013 – Direct Flow Medical®, Inc., a transcatheter heart valve company focused on improving patient outcomes, today announced that it...
Recent Comments